Zealand Pharma Announces Augmentation of its Management Team as it Continues its Growth Strategy

10-Mar-2010 - Denmark

Zealand Pharma A/S announced that Dr. Christian Grøndahl has been appointed Chief Scientific Officer, Mr. Mats Blom as Chief Financial Officer and Dr. John Hyttel as Senior Vice President for Operations.

Dr. Grøndahl, who will take up his duties as CSO April 1, 2010, has a DVM, PhD and DMedSci, all from Copenhagen University. Dr. Grøndahl has 20 years of experience in the medical sciences and has held positions of increasing responsibility at Novo Nordisk for the past 14 years. Until recently, he was Corporate Vice President for Strategic Alliances at Novo Nordisk. Dr. Grøndahl will have overall responsibility for Research and Development at Zealand Pharma A/S and for commercializing Zealand's strong pipeline of products.

Mr. Blom, whose appointment is effective March 2, 2010, received his BA from University of Lund and holds an MBA from the University of Navarra in Barcelona, Spain. Mr. Blom has worked in audit and corporate finance, has been the CFO of two public companies and until recently was CFO of Swedish Orphan International that recently merged with Biovitrum to form Swedish Orphan-Biovitrum of Stockholm. Mr. Blom will be responsible for all financial reporting and for co-ordinating corporate development finance activities at Zealand Pharma A/S. He replaces Mr. Mogens Vang Rasmussen who was at Zealand for 7 years, most recently as COO and CFO.

Dr. Hyttel who began his role as Senior Vice President for Operations on March 1, 2010, is a Founder of Zealand Pharma A/S in 1998. Dr. Hyttel holds degrees including a MSc and DSc from Copenhagen University. Dr. Hyttel served in increasing senior positions at H Lundbeck A/S for 30 years prior to joining Zealand. Dr. Hyttel has also served in senior positions at Zealand, most recently as Head of Regulatory Affairs. In his new position, Dr. Hyttel will be responsible for all operational activities at Zealand Pharma A/S.

https://www.bionity.com/en/news/114622/zealand-pharma-announces-augmentation-of-its-management-team-as-it-continues-its-growth-strategy.html